ask why
Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

The papers that matter: 15 December to 21 December 2025

The 10 most important of the 132 papers published that week and summarised on Y, ranked by what verified readers said would change practice, then by strength of design and size. Secondary analyses come last.
Women's health · Int J Gynaecol Obstet · 2025-12-15

Prospective IPD meta-analysis of 10 data sources (86,210 pregnant women with COVID-19, 4.4% hospitalised): non-hospitalised women had no increased risk of adverse outcomes; hospitalised women had higher risks of caesarean, preterm birth and low birthweight.

Meta-analysisn = 86,210
de Bruin et al. Adverse outcomes among pregnant women with COVID-19 according to hospitalization status: A prospective individual participant data meta-analysis in Europe and North America
Oncology · Cancer · 2025-12-15

Meta-analysis of 17 studies (10,396 adults) of allo-HSCT for blood cancers: fludarabine-melphalan vs fludarabine-busulfan was associated with better PFS (HR 0.90) and less relapse but higher treatment-related mortality (HR 1.44); OS did not differ.

Meta-analysisn = 10,396
Wannaphut et al. Outcomes of fludarabine-melphalan versus fludarabine-busulfan reduced-intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies: A systematic review and meta-analysis
Critical care and emergency · Ann Emerg Med · 2025-12-16

Stepped-wedge cluster RCT in 4 Australian EDs (9,944 adults with suspected ACS): in patients with presentation troponin ≤2 ng/L, the LEGEND rule-out strategy shortened mean stay by 3.6 hours, with no difference in 30-day events.

RCTn = 9,944
Greenslade et al. The Limit of Detection in the Emergency Department Trial (LEGEND): A Stepped-Wedge Cluster Randomized Trial to Rule Out Acute Myocardial Infarction and Reduce Hospital Length of Stay for Patients Presenting to the Emergency Department

Previous weekNext weekAll weeks

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.